EIF4E and cancer: eIF4E is abnormally expressed in various cancers, including lung cancer, esophageal squamous cell carcinoma, nasopharyngeal carcinoma, gastric cancer, uterine fibroids, and breast cancer, involved in the cell growth, proliferation, invasion, and apoptosis, and closely associated with poor survival [41–43].